Skip to main content
. 2021 Sep 15;27(23):6323–6332. doi: 10.1158/1078-0432.CCR-21-1704

Figure 2.

Figure 2. Forest plot representing subgroup analysis of ORR per IRC assessment based on Lugano classification (15) for patients with MZL in the MAGNOLIA study (BGB-3111–214). CHOP, cyclophosphamide, doxorubicin, vincristine, and prednisone. aTwo-sided Clopper–Pearson 95% CIs for ORR.

Forest plot representing subgroup analysis of ORR per IRC assessment based on Lugano classification (15) for patients with MZL in the MAGNOLIA study (BGB-3111–214). CHOP, cyclophosphamide, doxorubicin, vincristine, and prednisone. aTwo-sided Clopper–Pearson 95% CIs for ORR.